Literature DB >> 8133401

Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study.

B V Joypaul1, E L Newman, D Hopwood, A Grant, S Qureshi, D P Lane, A Cuschieri.   

Abstract

Mutations in the p53 nuclear oncogene are the most frequent genetic abnormalities encountered in human malignancies. Using the polyclonal antibody CM-1, we have examined the expression of the p53 oncoprotein immunohistochemically in archival material of normal, dysplastic, and malignant gastric mucosa. Abnormal expression of this protein was not observed in biopsies of normal gastric tissue (n = 30) but was detected in 22 of the 36 gastric cancers analysed (61 per cent). Nuclear staining was diffuse in 15 of the positive cancer cases, the remaining seven showing a more varied heterogeneous staining pattern. Abnormal p53 protein was not detected in mild (n = 14) or moderate (n = 16) gastric dysplasia but was present in 3 out of 15 severe dysplasia cases. The results suggest that expression of the p53 oncoprotein is a common finding in gastric cancer and occurs as a late event in the malignant transformation process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133401     DOI: 10.1002/path.1711700310

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Koki Kuwabara; Kunihiko Amano; Noriyasu Chika; Norimichi Okada; Tomonori Ohsawa; Youichi Kumagai; Keiichiro Ishibashi
Journal:  Mol Clin Oncol       Date:  2017-08-08

2.  TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.

Authors:  E D'Andrea; R Baffa; C Menin; M Montagna; M Rugge; L Chieco-Bianchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea.

Authors:  Nayoung Kim; Sung-Il Cho; Hye Seung Lee; Ji Hyun Park; Jee Hyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

4.  Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection.

Authors:  Fredrik Petersson; Kurt Borch; Lennart E Franzén
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

5.  Chronology of p53 protein accumulation in gastric carcinogenesis.

Authors:  M E Craanen; P Blok; W Dekker; G J Offerhaus; G N Tytgat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  Proliferative epithelial changes in ectopic gastric mucosa of Meckel's diverticula.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa.

Authors:  M J Brito; G T Williams; H Thompson; M I Filipe
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

Review 8.  Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis.

Authors:  M Anti; A Armuzzi; A Gasbarrini; G Gasbarrini
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

9.  Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method.

Authors:  Y Kitayama; H Sugimura; M Tanaka; S Nakamura; I Kino
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

Authors:  C Poremba; D W Yandell; Q Huang; J B Little; W Mellin; K W Schmid; W Böcker; B Dockhorn-Dworniczak
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.